期刊文献+

胸膜间皮瘤外科手术治疗效果观察

Pleural Mesothelioma Surgical Treatment Effect is Observed
下载PDF
导出
摘要 目的探讨胸膜间皮瘤外科手术治疗的效果。方法首先对胸膜间皮瘤患者进行手术以切去肺部肿瘤细胞扩散侵染的部分,再联用化疗药物或者局部强调放疗治疗。结果比较3组患者治疗后存活时间结果,手术联用组平均存活时间为14.3个月,化疗组相应的结果为11.2个月,放疗组的存活时间为11.9个月,手术组相比较其他两组存活时间延长明显,差异有统计学意义(P<0.05)。结论在对患者进行放疗和化疗前,可以选择合适的手术方式进行前导治疗。可提高疗效,减少局部复发和延长患者的存活时间。 Objective To observe the effect of the surgical treatment was pleural mesothelioma. Methods First of all, in patients with pleural mesothelioma underwent surgery to cut off part of the lung cancer cells spread infection, chemotherapy drugs or partial emphasis on radiation therapy. Results The table below for the three groups of patients survival time comparison results after treat- ment, surgery were the average survival time was 14.3 months, the corresponding results of chemotherapy group was 11.2 months, the radiotherapy survival time was 11.9 months, compared surgical group survival time prolong obviously the other two groups (P〈 0.05, the result is statistically significant. Conclusion In patients before radiotherapy and chemotherapy, can choose the right op- eration method for leading treatment. Can improve the curative effect, reduce local recurrence and prolong survival time of patients.
作者 董晓龙
出处 《中外医疗》 2013年第20期22-23,共2页 China & Foreign Medical Treatment
关键词 胸膜间皮瘤 肿瘤 外科手术 Pleural mesothelioma The tumor Surgery
  • 相关文献

参考文献5

二级参考文献23

  • 1姚小鹏,李强,白冲,黄怡,董宇超,商艳.224例胸腔积液胸腔镜检查术分析[J].中国内镜杂志,2006,12(2):191-193. 被引量:39
  • 2Kalmadi S R, Rankin C, Kraut M J, et al. Gemcitabine and cisplatin in unreseetable malignant mesothelioma of the pleural: a phase Ⅱ study of the Southwest Oncology Group (SWOG 9810) [J]. Lung Cancer, 2008, 60(2) :259-263.
  • 3Calvert A H, Hughes A N, Calvert P M, et al. ALIMTA in combination with carboplatin demonstrates clinical activity against malignant mesothelioma in a phase Ⅰ trial[J]. Lung Cancer,2000,29(1) :73-74.
  • 4Vogelzang N J, Rusthoven J J, Symanowski J, et al. Phase Ⅲ study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma[J]. J Clin Oncol, 2003,21(14) :2636-2644.
  • 5Boutin C, Rey F, Viallat J R. Prevention of malignant seeding after invasive diagnostic procedures in patients with plueral rues othelioma: a randomized trial of local radiotherapy[J]. Chest, 1995,108(3) :754-758.
  • 6Rusch V W, Piantadosi S, Holmes E C, et al. The role extrapleural pneumonectomy in malignant pleural mesothelioma. A lung cancer study group trial [J]. J Thorac Cardiovase Surg, 1991,102(1) : 1-9.
  • 7Sugarbaker D J, Flores R M, Jaklitsch M,et al. Resection margins, extrapleural nodal status, and cell type determine postop erative long-term survival in trimodality therapy of malignant pleural rnesothelioma: results in 183 patients[J]. J Thorae Cardiovasc Surg, 1999,117(1): 54-65.
  • 8Rusch V W, Rosenzweig K, Venkatraman E, et al. A phase Ⅱ trial of surgical resection and adjuvant high close hemithoracic radiation for malignant pleural mesothelioma[J]. J Thorac Cardiovasc Surg,2001,122(4):788-795.
  • 9Maziak D E, Gagliardi A, Haynes A E, et al. Sugieal management of malignant pleural mesothelioma: a systematic review and evidence summary[J]. Lung Cancer, 2005,48(2) : 157-169.
  • 10Rush V W, Saltz L, Venkatraman E, et al. A phase Ⅱ trial of pleureclomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesoyhelioma[J]. J Clin Oncol, 1994,12(6) : 1156-1163.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部